Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.

被引：0
|
作者：
Canzanello, VJ [1 ]
Schwartz, LL [1 ]
Taler, SJ [1 ]
Textor, SC [1 ]
Atwood, G [1 ]
Porayko, MK [1 ]
Wiesner, RH [1 ]
Krom, RAF [1 ]
机构：
[1] MAYO CLIN,ROCHESTER,MN
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1443 / 1443
页数：1
相关论文
共 50 条
  • [1] CyA to tacrolimus (FK506) conversion in liver transplant recipients
    Cuomo, O
    Iovine, L
    Carfora, T
    De Luca, M
    Di Palma, M
    Anello, R
    LIVER TRANSPLANTATION, 2004, 10 (06) : C39 - C39
  • [2] Effect of conversion from cyclosporine to tacrolimus on cardiovascular risk profile in renal transplant recipients
    Do, Wonseok
    Kwon, Eugene
    Kim, Geun-Hee
    Lee, Kyung Hee
    Kim, Kyu Yeun
    Kim, Minjung
    Yang, Youngae
    Yim, Taehoon
    Hwang, Inryang
    Lee, Sukyung
    Jung, Hee-Yeon
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    TRANSPLANTATION, 2016, 100 (07) : S691 - S691
  • [3] Population pharmacokinetic study of tacrolimus (FK506) in adult liver transplant recipients.
    Zahir, H
    Nelson, A
    Gleeson, M
    McCaughan, G
    McLachlan, AJ
    Akhlaghi, F
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 365 - 365
  • [4] Screening for hypomagnesemia in cyclosporine or FK 506 treated renal transplant recipients.
    Gupta, BK
    Glicklich, D
    TRANSPLANTATION, 1999, 67 (07) : S152 - S152
  • [5] Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy
    Ben-Ari, Z
    Mor, E
    Shaharabani, E
    Bar-Nathan, N
    Shapira, Z
    Tur-Kaspa, R
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (04) : 709 - 710
  • [6] BEST SINGLE TIME POINT MEASUREMENT CORRELATIONS WITH AUC FOR CYCLOSPORINE ( CSA) AND TACROLIMUS ( FK) IN HIV- INFECTED LIVER AND KIDNEY TRANSPLANT RECIPIENTS.
    Tan-Tam, C. C.
    Frassetto, L. A.
    Barin, B.
    Browne, M.
    Wolfe, A. R.
    Stock, P. G.
    Roland, M.
    Benet, L. Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S22 - S23
  • [7] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    Wallemacq, PE
    Furlan, V
    Möller, A
    Schäfer, A
    Stadler, P
    Firdaous, I
    Taburet, AM
    Reding, R
    De Clety, SC
    De Goyet, JD
    Sokal, E
    Lykavieris, L
    Van Leeuw, V
    Bernard, O
    Otte, JB
    Undre, NA
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (03) : 367 - 370
  • [8] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    P. E. Wallemacq
    V. Furlan
    A. Möller
    A. Schäfer
    P. Stadler
    I. Firdaous
    A -M. Taburet
    R. Reding
    S. Clement De Clety
    J. De Ville De Goyet
    E. Sokal
    L. Lykavieris
    V. Van Leeuw
    O. Bernard
    J. B. Otte
    N. A. Undre
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 367 - 370
  • [9] Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: A single center experience
    Ichikura, H
    Tanabe, K
    Tokumoto, T
    Shimuzu, T
    Ishikawa, N
    Harano, M
    Inui, M
    Manu, M
    Ito, S
    Shimmura, H
    Okuda, H
    Yagisawa, T
    Fuchinoue, S
    Toma, H
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1733 - 1735
  • [10] Cardiovascular risk profile before and after tacrolimus conversion in kidney transplant recipients.
    Luan, Fu L.
    Miles, Clifford D.
    Blosser, Christopher
    Cibrik, Diane M.
    Norman, Silas
    Chopra, Pavan
    Ojo, Akinlolu A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 534 - 534
12345